Drug intelligence / Profile preview

anti-HPV egg yolk immunoglobulin

Development stage
Unknown
Lead developer
Henan Xixiai Biotechnology
Modality
Antibody-Based Therapeutics
Administration
Vaginal
01

Overview

Xixiai HPV egg yolk antibody gynecological gel is a topical biologic product containing Immunoglobulin Y (IgY) extracted from the yolks of eggs laid by hens immunized against Human Papillomavirus (HPV). As a form of passive immunotherapy, the IgY antibodies are designed to specifically bind and neutralize HPV virions (typically targeting the L1 capsid protein) within the vaginal and cervical environment. This action prevents the virus from entering host epithelial cells, thereby inhibiting viral replication and promoting the clearance of persistent HPV infections. The gel is primarily utilized as an adjuvant therapy in women who have undergone cervical conization for high-grade squamous intraepithelial lesions (HSIL) to facilitate HPV DNA conversion to negative and reduce the risk of disease recurrence.

Brand names
Xixiai喜喜爱
Other names
Xixiai HPV egg yolk antibody gynecological gelHPV egg yolk antibody gelanti-HPV IgY gelHPV egg yolk antibody
02

Targets

HPV L1 (Human papillomavirus L1 capsid protein)

Beyond the preview

Go deeper on anti-HPV egg yolk immunoglobulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-HPV egg yolk immunoglobulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call